FDA expands use of Amgen's blockbuster drug

(Reuters) - Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news